Norges Bank’s BioAtla BCAB Stock Holding History

Norges Bank’s Portfolio BCAB Stock Details BCAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-7,782	Closed	-$230K	–	1757
2024 Q4	$230K	Hold	7,782	–	–	﹤0.01%	1825
2024 Q3	$685K	Sell	7,782 -1,982	-20%	-$166K	﹤0.01%	1762
2024 Q2	$669K	Hold	9,764	–	–	﹤0.01%	1854
2024 Q1	$1.68M	Hold	9,764	–	–	﹤0.01%	1752
2023 Q4	$1.2M	Hold	9,764	–	–	﹤0.01%	1843
2023 Q3	$830K	Hold	9,764	–	–	﹤0.01%	1901
2023 Q2	$1.46M	Buy	+9,764	New	+$1.68M	﹤0.01%	1897
2022 Q2	–	Sell	-5,024	Closed	-$1.26M	–	2068
2022 Q1	$1.26M	Buy	+5,024	New	+$2.1M	﹤0.01%	2027
2021 Q1	–	Sell	-200	Closed	-$340K	–	2137
2020 Q4	$340K	Buy	+200	New	+$334K	﹤0.01%	2096

Other funds holding BCAB

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Norges Bank's BCAB Position: Q1 2025 in Review

Norges Bank sold out of BioAtla (BCAB) in Q1 2025, closing a stake of 7,782 shares — an estimated $230K sold.

Norges Bank first reported a position in BCAB in Q4 2020 and held it in 9 quarters. The position peaked at $1.68M in Q1 2024. 41 funds tracked by Wall St. Rank hold BCAB as of Q1 2025.

Norges Bank reported no remaining BioAtla position as of Q1 2025 after selling out during the quarter.
Norges Bank sold 7,782 BioAtla shares in Q1 2025, an estimated $230K.
Norges Bank first reported a position in BioAtla in Q4 2020 and held it in 9 quarters.
Norges Bank's BioAtla position peaked at $1.68M in Q1 2024.
41 funds tracked by Wall St. Rank held BioAtla as of Q1 2025.

Based on Norges Bank's 13F filing for Q1 2025, filed 13 May 2025.